Trimurthi Ltd (BSE: 536565) is a Hyderabad, Telangana-based company in the Health Care Distributors industry. With a market capitalisation of ₹170 Cr, it ranks #2,781 by market cap among the 6,189 Indian listed companies on FinBizNet, and #1 of 11 in Health Care Distributors. At ₹59.54 (as of 26 Oct 2026), the share price is 35.3% below its 52-week high of ₹92.00 and 29.4% above its 52-week low of ₹46.01. The share price is up 48.6% over one year and down 14.9% over three months.
| Current Price | ₹59.54 |
|---|---|
| Market Cap | ₹170 Cr |
| BSE Code | 536565 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors |
| P/E Ratio | 49.1 |
| Return on Equity | 7.99% |
| Return on Assets | 3.58% |
| 52-Week Range | ₹46.01 – ₹92.00 |
| 1-Year Price Change | +48.6% |
| 3-Month Price Change | -14.9% |
| Beta (1Y) | 0.37 |
| Dividend Yield | 0.00% |
| Headquarters | Hyderabad, Telangana |
| Website | www.trimurthidrugs.com |
Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.
1. Pharma Business-This segment engages in the trading and distribution of pharmaceutical products. 2. Financial Services-This segment provides financial services. 3. Trading in Shares-This segment engages in the trading of shares. 4. Segment Adjustment-0
1. Pharma Business-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Trimurthi Ltd | ₹170 Cr | 49.1 | 7.99% | — | +48.6% |
| Achyut Healthcare Ltd | ₹168 Cr | 535.4 | 0.95% | — | +15.0% |
| Vaidya Sane Ayurved Laboratories | ₹154 Cr | — | 11.99% | — | -43.5% |
| Balaxi Pharmaceuticals Ltd | ₹115 Cr | 81.4 | 0.59% | ₹81 Cr | -50.2% |
| Chanfta Bhagat Pharma Ltd | ₹29 Cr | 9.7 | 2.91% | — | -5.1% |
| Medico Intercontinental Ltd | ₹23 Cr | -7.1 | -27.14% | ₹14 Cr | -34.9% |
| Rubra Medicaments Ltd. | ₹20 Cr | 13.4 | 12.67% | — | -37.7% |
| Zenlabs Ethica Ltd | ₹18 Cr | -9.1 | -20.44% | — | -12.8% |
| Nexus Surgical & Medicare Ltd | ₹14 Cr | 18.6 | 51.41% | — | +76.5% |
Listed by market capitalisation. Ratios are shown for context only.
Trimurthi Ltd is trading at ₹59.54, with a market capitalisation of ₹170 Cr.
Trimurthi Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).
Trimurthi Ltd has a P/E of 49.1 and a return on equity of 7.99%.
Trimurthi Ltd is listed on the BSE under the scrip code 536565.
Trimurthi Ltd's share price is up 48.6% over one year and down 14.9% over three months. Its 52-week range is ₹46.01 to ₹92.00.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.